PharmDart Consulting (OPC) Pvt Ltd is a registered company aiming to provide excellent online and offline services, consultancy and training to the students, teachers, researchers, institutes, and corporates. It is Central India's one and first of its kind "First-in-class Education Platform" having a vision of transforming values of learners through exchange of knowledge between academia and business. Since its inception, we have provided trainings, workshops to number of individuals from all the verticals and streams. We are ISO 9001:2015 certified training organization enhancing the standards of profession and professionals. Through our unique "Pharmacist Centric Model", we have been able to conceptualize and created a wagon-wheel integrating Biotechnology, Clinical Diagnostics, Healthcare IT, Medical Devices, Medical Imaging, Pharmaceuticals and Animal health. Our PDCast is another unique platform which enable students and professionals to listen and gain knowledge about topic of their choices. The platform can be access from anywhere and it is available round the clock.

PharmDart Consulting (OPC) Pvt. Ltd., a registered Micro Enterprise under UDYAM-CG-14-0094487, specializes in publication with a focus on publishing research in the form of Industry reports, research with ISSN, ISBN, reports on market analysis, and other educational supports as well. Established in 2020 in Raipur, Chhattisgarh, we are committed to delivering innovative, data-driven, and socially impactful solutions across multiple sectors.

International Journal of Progressive Human Advancement, Research, and Multidisciplinary Development in Applied Research & Technology (IJPHARMDART) is an international, open-access, peer-reviewed, multidisciplinary scholarly online journal dedicated to helping researchers share their work with a global audience. As an online, open-access platform, IJPHARMDART ensures that published research reaches a wide and diverse readership.

The journal welcomes submissions from all fields, including but not limited to General Management, International Business, Economics, Technological Innovation, Science, Engineering, Healthcare, Agriculture and Fisheries Development, Women’s Empowerment, Law and Justice, Political Science, Arts and Humanities, Education, and Library Science. These topics are indicative rather than exhaustive; the editorial board encourages the submission of high-quality, original research from any academic discipline.

 PharmDart joined hand-in-hand with multiple institutions to bridge the gap between academia and corporate!!

 p-waste Initiative - preventing expired, unused, breakage household medicines reaching landfills and water supply system

Currently, there is no regulation of generic expiry medicines collection from Health Centres, Medical stores and Medical Stockiest. Due to this gap, facilities are disposing waste in haphazard and indiscriminate manner causing serious health hazards. Pharmaceutical waste includes all expired, unused, contaminated or discontinued drugs (also known as medicines or chemicals) that can no longer be used for humans or animals. Broadly speaking, pharmacy waste falls in one of two categories; it is either hazardous or non-hazardous (as defined by the EPA) to health.

Objectives

 To collect & receive the Pharmaceutical Waste from PHC, CHC, DHs, Retail and Wholesale facilities

 To ensure proper storage of the wastes as per the classification, characterization and mode of treatment and disposal

 To optimize the storage and disposal cost by management practices and provide the very economical services to the retailers and wholesalers

 To educate and make the individuals of health centres, retail and wholesale business aware of storing the expiries, breakages and other wastes in a scientific manner

 To conduct the public awareness program Responsibilities

 To educate all regarding proper pharmaceutical wastes management.

 Take feedback from retailers, wholesalers for quality on services for continual improvements.

 Provide necessary training to the shop staff regarding handling wastes.

 Provide containers for storage and to track the necessary information and keep it in records.

 All the wastes collected should have proper label and details.

Pharmaceutical Waste Collection

 We would provide waste collection service to all clients all business working days.

 Facility will have number of vehicles for waste collection with GPS enabled.

 We would assign number of clients per vehicle for smooth operations to collect the pharmaceutical waste.

 Check log sheet entries of waste collected from shops to ensure the proper services to our clients.

Market Scenario:

In Chhattisgarh, there are approximately 4,500 health centres/sub centres and 12,000 shops who deal with pharma business (retailers, stockiest, C&F etc.).  Similarly, from the households also, many medicines get expired and thrown in the garbage or flush off in the toilet.

 No generic manufacturer, take back the expired generic medicines from the retailer, stockiest or C&F and these expired medications are settled personally.

About the Journal

The International Journal of Progressive Human Advancement, Research, and Multidisciplinary Development in Applied Research & Technology (IJPHARMDART) is a peer-reviewed, open-access, international multidisciplinary journal committed to promoting high-quality scholarly communication across diverse academic disciplines.

Journal Details

IJPHARMDART publishes cutting-edge research papers, reviews, and academic discussions that contribute to the advancement of knowledge in multiple domains. The journal welcomes submissions from various fields, including but not limited to General Management, International Business, Economics, Technological Innovations, Engineering, Healthcare, Agriculture and Fisheries Development, Women Empowerment, Law and Justice, Political Science, Arts and Humanities, Education, and Library Science. These subject areas are illustrative rather than exhaustive, and the Editorial Board remains open to publishing rigorous and impactful research from any other area of scholarly inquiry.

As an online open-access platform, IJPHARMDART ensures global visibility and accessibility, enabling researchers and academicians worldwide to disseminate their work to a broad and diverse audience.

Aim

The International Journal of Progressive Human Advancement, Research, and Multidisciplinary Development in Applied Research & Technology (IJPHARMDART) aims to serve as a dynamic academic forum for the publication of original, high-quality research that enhances understanding across the natural sciences, social sciences, technology, and humanities.

The journal seeks manuscripts that demonstrate significance, originality, and scientific rigor, contributing meaningfully to academic discourse and global development. Through the dissemination of innovative research, IJPHARMDART aspires to advance interdisciplinary knowledge, foster intellectual collaboration, and stimulate scholarly dialogue among researchers, practitioners, and policy-makers.

IJPHARMDART provides a platform for academics and professionals engaged in multidisciplinary research to share insights, exchange perspectives, and publish studies that broaden collective understanding of societal, scientific, and developmental phenomena.

The journal publishes research articles, notes, and book reviews that explore the dynamics of global development and transformation across diverse regions, societies, cultures, and systems.

Vision

“To be a leading global platform that unites academicians and researchers from all disciplines to publish impactful, interdisciplinary research fostering innovation, knowledge creation, and sustainable global development.”

Mission

The mission of the International Journal of Progressive Human Advancement, Research, and Multidisciplinary Development in Applied Research & Technology (IJPHARMDART) is to:

Facilitate scholarly dialogue by offering a platform for eminent academicians and decision-makers to share perspectives on contemporary research issues.

Promote interdisciplinary collaboration by encouraging research that bridges traditional academic boundaries.

Shape the future of academic discourse through the publication of influential research that drives innovation and intellectual advancement across disciplines.

Scope and Relevance

IJPHARMDART welcomes original, empirical, and theoretical research papers that explore the intersections of human resource management, marketing, finance, healthcare, life sciences, politics, psychology, engineering, education, security, economics, culture, and social development.

The journal also encourages submissions on technological innovations and emerging trends influencing modern society. Articles incorporating relevant historical perspectives are also accepted when they contribute to the advancement of the central research arguments.

Types of Manuscripts Accepted

IJPHARMDART invites submissions in the following categories:

Original Research Articles: Empirical papers presenting new findings from experimental, clinical, or preclinical research, including cost-effectiveness studies, international comparative analyses, diagnostic tests, and randomized controlled trials.

Review Articles: Comprehensive analyses offering critical evaluations and synthesized insights on specific themes or topics.

Case Studies: In-depth examinations of particular cases that highlight practical applications, interventions, or outcomes, along with reflective discussions and implications.

Editorials: Scholarly commentaries written by the editorial board or invited experts, addressing emerging trends, contemporary issues, or perspectives on recent publications.

Book Reviews: Evaluative reviews of newly published academic books relevant to the journal’s areas of focus, authored by subject-matter experts.

Abstracting and Indexing

The International Journal of Progressive Human Advancement, Research, and Multidisciplinary Development in Applied Research & Technology (IJPHARMDART) is indexed in multiple international academic databases. For details, please refer to the journal’s official indexing information page.

All published articles are assigned Digital Object Identifiers (DOIs) via Zenodo. To support accurate citation, enhanced visibility, and long-term digital preservation, the complete metadata and, where applicable, the full-text of each article are archived in Zenodo.

Google Scholar

Research-Gate

All published articles are assigned Digital Object Identifiers (DOIs) via Zenodo. To support accurate citation, enhanced visibility, and long-term digital preservation, the complete metadata and, where applicable, the full-text of each article are archived in Zenodo

Editor-in-Chief

Prof. (Dr.) Shekhar Verma

Professor, Department of Pharmacy,

Guru Ghasidas University, Bilaspur, Chhattisgarh

shekharpharma@gmail.com

ORCID : 0000-0002-5470-5976 

Google Scholar: scholar.google.com/citations

GGU Profile: ggu.ac.in/department/pharmacy/faculty/shekharverma/

Managing Editor

1. Prof (Dr.) Umesh Gupta

Dean, MSMSR & MSBS

MATS University, Raipur, Chhattisgarh

drumeshgupta@matsuniversity.ac.in

ORCID : orcid.org/0009-0008-5852-0689

Google Scholar: scholar.google.co.in/citations

University Profile: matsuniversity.irins.org/profile/501482

Dr. Ravi Kishor Agrawal

Professor (Assistant), MSMSR,

MATS University, Raipur, Chhattisgarh

drravikishora@matsuniversity.ac.in

ORCID : 0009-0001-2768-4946

Google Scholar: scholar.google.com/citations

MATS University Profile: matsuniversity.ac.in/mats_school_of_management_and_research/faculty.php

Members of Editorial Board

1. Dr. S. Senthilkumar

Professor (Assistant) and Head of Department, Management Department,

Skyline University, Nigeria

senthil@sun.edu.ng

ORCID : 0000-0002-8209-7090

Google Scholar:scholar.google.com/citations

Skyline University Profile - sun.edu.ng/dr-s-senthil-kumar/

2. Dr Jayendira Sankar Pakkirisankar

Associate Professor,

Programme/Department Head - International Business

University of Technology, Bahrain

jpsankar@utb.edu.bh

Google Scholar: scholar.google.com/citations

University Profile: www.utb.edu.bh/wp-content/uploads/2024/11/UTB-FACULTY-MANUAL.pdf

3. Dr. Muhammed Yousoof

Assistant Professor, Department of Management Information Systems

Dhofar University, Sultanate of Oman

mismail@du.edu.om

ORCID : https://orcid.org/0000-0002-1587-5542

Google Scholar: scholar.google.com/citations

College Profile: oracleapex.com/ords/r/du/dhofar-university-staff/college-of-commerce-business-administration

4. Dr KV Elumalai

Associate Professor, Department of English Language

King Saud University,

Kingdom of Saudi Arabia

ekesavan@ksu.edu.sa

Google Scholar: scholar.google.com/citations

Profile - faculty.ksu.edu.sa/en/ekesavan

5. Dr Shashank Tewari

Assistant Professor

Department of Pharmaceutical Chemistry

shashank.tewari@manipal.edu

Linkedin Profile: www.linkedin.com/in/shashanktewari1989/

University: www.manipal.edu/mcops-manipal/department-faculty/faculty-list/ShashankTewari/_jcr_content.html

6. Ms. Nawdeep Kaur

Professor (Assistant), MSBS,

MATS University, Raipur, Chhattisgarh

nawdeepk@matsuniversity.ac.in

ORCID : 0009-0006-2074-0913

University Profile: matsuniversity.ac.in/mats_school_of_bussines_studies/faculty.php

 EDITORS RESPONSIBILTIY

Editors are responsible for upholding the quality, integrity, and ethical standards of all materials published in the journal. They must take all necessary steps to ensure that the content meets the journal’s objectives and aligns with its editorial and academic standards. It is recognized that different journals or sections within a journal may have distinct goals and quality benchmarks.

Editors should address complaints and ethical concerns promptly, fairly, and transparently. A clear and accessible procedure for handling complaints must be communicated within the journal. This process should include a mechanism for escalating unresolved issues and guidance on referring such matters to the Committee on Publication Ethics (COPE), where applicable.

DUPLICATE SUBMISSION AND PUBLICATION POLICY

The journal maintains a strict policy against duplicate submission and publication. This refers to the practice of:

·       Submitting the same research or substantially similar work to more than one journal, either concurrently or at different times.

·       Republishing previously published material, including translations of articles, without proper authorization or disclosure.

·       Re-submitting open-access articles that have already been published elsewhere.

Any form of duplicate or redundant publication is considered unethical and will not be accepted. Authors are expected to ensure that their submissions are original and have not been published or submitted elsewhere.

 

 

 Since Journal is completely freely available and does not receive funding from any individual or group. The charges include amount for the compliance of administrative and publication work.

JOURNALS

Click here to pay: pharmdart.org/iife.php

 Processing Charges Includes:

·       The research article will be published online permanently, with a limit of 12 pages. After 12 pages, processing charges will be extra.

·       It will also be formatted and edited.

·       It will be submitted to various indexing services.

·       An e-certificate of publication will be provided.

BOOKS

Click here to pay: pharmdart.org/iife.php

MEMBERSHIP FEES OF CGSPST (Registered & Government Affiliated Society)

·       STUDENT MEMBERSHIP (Annual) - ₹100

·       ORDINARY MEMBERSHIP (Annual)- ₹200

·       CONVENER MEMBERSHIP - ₹10000

·       LIFETIME MEMBERSHIP – ₹5000

·       INSTITUTIONAL MEMBERSHIP - ₹10000 

Click here to pay: pharmdart.org/iife.php

AWARDS FOR MULTIPLE CATEGORY BOTH INDIVIDUAL AND ORGANIZATIONAL 

Click here to pay: pharmdart.org/iife.php

NFC ACADEMIC RESEARCH CARD

Upgrade Your Academic Presence @1499/- Buy it now

Click here to pay: pharmdart.org/iife.php

Anti-Plagiarism Policy

International Journal of Progressive Human Advancement, Research, and Multidisciplinary Development in Applied Research & Technology (IJPHARMDART)

IJPHARMDART maintains the highest standards of academic integrity and ethical publishing. Any form of plagiarism is considered a serious violation of publication ethics and is strictly prohibited. Manuscripts found to contain plagiarized content may be rejected at any stage of the review or publication process.

Meaning of Plagiarism

Plagiarism refers to the use of another individual’s intellectual work, ideas, expressions, data, or creative output without appropriate acknowledgment, thereby presenting it as one’s own original contribution.

Forms of Plagiarism Include (but are not limited to):

• Copying text directly from websites, journals, books, or other sources without proper citation

• Submitting another person’s academic work (assignment, article, project, or thesis) under one’s own name

• Reproducing sentences, paragraphs, or concepts from published material without quotation or reference

• Using images, tables, figures, charts, diagrams, audio, or visual content without permission or citation

• Paraphrasing research findings or ideas without crediting the original source

• Purchasing or borrowing academic content and submitting it as original work

• Structuring content in the same sequence and framework as the source material without attribution

Author’s Responsibility and Declaration

By submitting a manuscript to IJPHARMDART, the author(s) confirm and agree that:

• They clearly understand that plagiarism is unethical and unacceptable in academic publishing

• The submitted work is original and has not been copied, duplicated, or misrepresented

• All sources of information, whether published or unpublished, have been properly cited and referenced

• Any contribution derived from the work of others has been duly acknowledged

• The author(s) bear full responsibility for any oversight, incomplete citation, or ethical violation

Anti-Plagiarism Declaration

The author(s) declare that they have carefully read and understood the plagiarism policy of IJPHARMDART. The submitted manuscript is the outcome of independent scholarly research. All references, quotations, and paraphrased materials have been clearly identified and cited. No material other than those appropriately acknowledged has been used. The manuscript has neither been published previously nor is it under consideration elsewhere.

Guidelines to Prevent Plagiarism

Authors are encouraged to follow these best practices:

• Familiarize yourself with proper citation and referencing standards relevant to your discipline

• Maintain accurate source details while taking notes during research

• Always verify and refer to original sources rather than secondary or copied web content

• Use plagiarism detection tools before submission to ensure originality

• When unsure about attribution, provide a citation—over-citation is preferable to under-citation

IJPHARMDART is committed to promoting ethical research practices and expects authors to uphold integrity, originality, and transparency in scholarly communication.